Clinical Trial

Intermittent Fasting, Mediterranean Diet and NAFLD

Study acronym: RC2024-21
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 26, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effects of Intermittent Fasting (IF) 14/10 compared with the Low Glycemic Index Mediterranean Diet on NAFLD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-23.
Trial Details
NCT Number NCT06615817
Lead Sponsor Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Conditions NAFLD, Obesity, Intermittent Fasting, Mediterranean Diet
Enrollment 60 participants
Start Date 2025-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-26